LUCIRA HEALTH INC (LHDX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:LHDX • US54948U1051

0.4523 USD
-0.11 (-19.23%)
At close: Mar 3, 2023
0.405 USD
-0.05 (-10.46%)
After Hours: 3/3/2023, 8:01:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LHDX. LHDX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. LHDX has a bad profitability rating. Also its financial health evaluation is rather negative. LHDX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • LHDX had negative earnings in the past year.
  • In the past year LHDX has reported a negative cash flow from operations.
LHDX Yearly Net Income VS EBIT VS OCF VS FCFLHDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -20M -40M -60M -80M -100M

1.2 Ratios

  • LHDX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHDX Yearly ROA, ROE, ROICLHDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 200 -200

1.3 Margins

  • LHDX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LHDX Yearly Profit, Operating, Gross MarginsLHDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • LHDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LHDX has been increased compared to 1 year ago.
  • LHDX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LHDX Yearly Shares OutstandingLHDX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M
LHDX Yearly Total Debt VS Total AssetsLHDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

  • LHDX has an Altman-Z score of -2.89. This is a bad value and indicates that LHDX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.89, LHDX is doing worse than 67.76% of the companies in the same industry.
  • LHDX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.48, LHDX is doing worse than 67.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -2.89
ROIC/WACCN/A
WACC8.96%
LHDX Yearly LT Debt VS Equity VS FCFLHDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M -100M

2.3 Liquidity

  • A Current Ratio of 1.46 indicates that LHDX should not have too much problems paying its short term obligations.
  • LHDX has a Current ratio of 1.46. This is amonst the worse of the industry: LHDX underperforms 84.11% of its industry peers.
  • A Quick Ratio of 0.79 indicates that LHDX may have some problems paying its short term obligations.
  • The Quick ratio of LHDX (0.79) is worse than 87.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 0.79
LHDX Yearly Current Assets VS Current LiabilitesLHDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • LHDX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.60%.
  • LHDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 564.27%.
EPS 1Y (TTM)-84.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-570.21%
Revenue 1Y (TTM)564.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%129.63%

3.2 Future

  • Based on estimates for the next years, LHDX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.35% on average per year.
  • The Revenue is expected to grow by 30.23% on average over the next years. This is a very strong growth
EPS Next Y83%
EPS Next 2Y25.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year201.55%
Revenue Next 2Y30.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LHDX Yearly Revenue VS EstimatesLHDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M 200M
LHDX Yearly EPS VS EstimatesLHDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LHDX. In the last year negative earnings were reported.
  • Also next year LHDX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHDX Price Earnings VS Forward Price EarningsLHDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHDX Per share dataLHDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LHDX's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.35%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LHDX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

LUCIRA HEALTH INC

NASDAQ:LHDX (3/3/2023, 8:01:46 PM)

After market: 0.405 -0.05 (-10.46%)

0.4523

-0.11 (-19.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-09
Earnings (Next)05-10
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.86%
Ins Owner Change0%
Market Cap18.36M
Revenue(TTM)212.13M
Net Income(TTM)-143.28M
Analysts43.33
Price Target0.77 (70.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-367.7%
Min EPS beat(2)-705.63%
Max EPS beat(2)-29.76%
EPS beat(4)2
Avg EPS beat(4)-10.85%
Min EPS beat(4)-705.63%
Max EPS beat(4)590.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.94%
Min Revenue beat(2)-14.7%
Max Revenue beat(2)2.82%
Revenue beat(4)3
Avg Revenue beat(4)9.87%
Min Revenue beat(4)-14.7%
Max Revenue beat(4)47.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-280.95%
EPS NY rev (1m)0%
EPS NY rev (3m)43.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-52.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-3.19
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-2.67
FCFYN/A
OCF(TTM)-2.03
OCFYN/A
SpS5.23
BVpS1.5
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 398.51%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 0.79
Altman-Z -2.89
F-Score2
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)2388.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-570.21%
EPS Next Y83%
EPS Next 2Y25.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)564.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%129.63%
Revenue Next Year201.55%
Revenue Next 2Y30.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-193.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-352.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-347.8%
OCF growth 3YN/A
OCF growth 5YN/A

LUCIRA HEALTH INC / LHDX FAQ

Can you provide the ChartMill fundamental rating for LUCIRA HEALTH INC?

ChartMill assigns a fundamental rating of 2 / 10 to LHDX.


What is the valuation status for LHDX stock?

ChartMill assigns a valuation rating of 3 / 10 to LUCIRA HEALTH INC (LHDX). This can be considered as Overvalued.


How profitable is LUCIRA HEALTH INC (LHDX) stock?

LUCIRA HEALTH INC (LHDX) has a profitability rating of 0 / 10.